Keyword: respiratory disease

News

GSK to Buy Respiratory Drug Developer Aiolos Bio

10.01.2024 -

GSK has agreed to acquire biotech Aiolos Bio for a $1 billion upfront payment and up to $400 million for the achievement of certain milestones. Founded just last year...

News

AstraZeneca and Pieris Link on Respiratory Disease

17.05.2017 - AstraZeneca is to collaborate with US-based Pieris Pharmaceuticals to develop novel inhaled drugs for respiratory diseases. The deal will leverage Pieris’ Anticalin platform and...